Rewriting the DSM
Multiple Choice: Customizing Insulin Therapy
In-Office Drug Testing for Retinal Conditions
Clinical Care Implications of ALLHAT
The Potential of Immunotherapy in Type 1 Diabetes
Emerging Insulin Pump Technology
Interventions Targeting Impaired Glucose Tolerance
The ARBITER 6-HALTS Trial: Clinical Implications
How Will Pharmacogenomics Play a Role in Diabetes Therapy?
DPP-4 Inhibitors: A New Class of Medications
Charles Turck, PharmD, BCPS, BCCCP
PeerThe Importance of Immunizations for Diabetic Patients
Drug Delivery Systems in the Management of Diabetes
Sodium-Glucose Transporters: A New Class of Diabetes Medications